MTD vs DGX — Key Metrics
| Metric | MTD (METTLER TOLEDO INTERNATIONAL INC) | DGX (QUEST DIAGNOSTICS INC) |
|---|---|---|
| Price | 1737.26 | 259.69 |
| Market Cap | 34.55 Billion | 28.57 Billion |
| P/E (TTM) | 37.63 | 25.51 |
| P/B (Quarterly) | 441.074 | 3.487 |
| P/S (TTM) | 8.23 | 2.41 |
| Net Profit Margin (TTM) | 22.2 | 9.5 |
| Gross Margin (TTM) | 60.4 | 33.1 |
| ROE (TTM) | 14966.1 | 15.2 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Underperform
Recommendation Summary
Stock MTD is projected to greatly underperform the market, stock DGX is projected to underperform the market. Upfront Recommendation: DGX.
Financial Metrics
| MTD | Metrics | DGX |
|---|---|---|
| $1,737.26 | Price | $259.69 |
| — | Market Capitalization | — |
| 37.63 | Price to Earnings Ratio | 25.51 |
| 8.23 | Price to Sales | 2.41 |
| 39.69 | Price to FCF Ratio | 20.78 |
| 13.63 | Price to Gross Profit | 7.29 |
| 25.11 | Price to Current Assets | 9.17 |
MTD vs DGX at a glance
Mettler Toledo International INC (MTD) and Quest Diagnostics INC (DGX) are both Diagnostics & Research companies in the Healthcare sector. MTD is the larger, at $34.6 billion in market value against $28.6 billion for DGX, about 1.2 times the size.
On trailing-twelve-month figures, MTD trades at 37.6 times trailing earnings and DGX at 25.5; net profit margins are 22.2% and 9.5%.
The Upfront Investment model currently rates MTD Greatly Underperform and DGX Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.